AN EFFICIENT SYNTHESIS OF 3-OXO-1,2,3,4-TETRAHYDROPYRROLO[1,2-α]PYRAZINE-1-CARBOXAMIDES USING NOVEL MODIFICATION OF UGI CONDENSATION

[1]  Alexey P. Ilyn,et al.  An efficient synthesis of novel heterocycle-fused derivatives of 1-oxo-1,2,3,4-tetrahydropyrazine using Ugi condensation , 2005 .

[2]  A. V. Nikitin,et al.  New four-component Ugi-type reaction. Synthesis of heterocyclic structures containing a pyrrolo[1,2-a][1,4]diazepine fragment. , 2005, The Journal of organic chemistry.

[3]  J. Randolph,et al.  Peptidomimetic inhibitors of HIV protease. , 2004, Current topics in medicinal chemistry.

[4]  Eberhardt Herdtweck,et al.  A Versatile Synthesis of 6-Oxo-1,4,5,6-tetrahydro-pyrazine-2-carboxylic Acid Methyl Esters via MCR Chemistry , 2004 .

[5]  S. Tamura,et al.  Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors. , 2003, Current opinion in pharmacology.

[6]  D. Romo,et al.  Enantioselective total synthesis of (+)-dibromophakellstatin. , 2003, Journal of the American Chemical Society.

[7]  R. Tapia,et al.  Synthesis and Antileishmanial Activity of Indoloquinones Containing a Fused Benzothiazole Ring , 2002 .

[8]  T. Torroba,et al.  Synthesis of thiomorpholines by an intramolecular Ugi reaction , 2002 .

[9]  A. Colson,et al.  Solid-supported synthesis of putative peptide beta-turn mimetics via Ugi reaction for diketopiperazine formation. , 2002, Journal of combinatorial chemistry.

[10]  T. Arrhenius,et al.  A convenient solution and solid-phase synthesis of Δ5-2-oxopiperazines via N-acyliminium ions cyclization , 2002 .

[11]  W. Herlihy,et al.  Unique Structures Generated by Ugi 3CC Reactions Using Bifunctional Starting Materials Containing Aldehyde and Carboxylic Acid. , 1999, The Journal of organic chemistry.

[12]  M. Murata,et al.  Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners. , 1998, Journal of medicinal chemistry.

[13]  R. Gould,et al.  Non-peptide glycoprotein IIb/IIIa inhibitors. 6. Design and synthesis of rigid, centrally constrained non-peptide fibrinogen receptor antagonists , 1995 .

[14]  H. Stetter,et al.  Herstellung bi‐ und tricyclischer Pyrrol‐Systeme , 1980 .

[15]  K. Lempert,et al.  Synthesis of Pyrroles and a 1,2-Dihydropyrrolo[1,2-a]pyrazin-3(4H)-one Identified as Maillard Reaction Products. , 1979 .